Theranostic imaging is a rapidly expanding field that is showing significant promise for precision medicine of cancer. Innovations in the development of novel nanoparticles that can be used to deliver therapeutic cargo to cancer cells, stromal cells, and microenvironments, are providing exciting new roles for MRI and MRS in combined detection and therapeutic strategies for cancer-specific treatments.
This abstract and the presentation materials are available to members only; a login is required.